Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease

Martial Rey, Menglin Yang, Linda Lee, Ye Zhang, Joey G Sheff, Christoph W Sensen, Hynek Mrazek, Petr Halada, Petr Man, Justin L McCarville, Elena F Verdu, David C Schriemer

Research output: Contribution to journalArticle

Abstract

Celiac disease is triggered by partially digested gluten proteins. Enzyme therapies that complete protein digestion in vivo could support a gluten-free diet, but the barrier to completeness is high. Current options require enzyme amounts on the same order as the protein meal itself. In this study, we evaluated proteolytic components of the carnivorous pitcher plant (Nepenthes spp.) for use in this context. Remarkably low doses enhance gliadin solubilization rates, and degrade gliadin slurries within the pH and temporal constraints of human gastric digestion. Potencies in excess of 1200:1 (substrate-to-enzyme) are achieved. Digestion generates small peptides through nepenthesin and neprosin, the latter a novel enzyme defining a previously-unknown class of prolyl endoprotease. The digests also exhibit reduced TG2 conversion rates in the immunogenic regions of gliadin, providing a twin mechanism for evading T-cell recognition. When sensitized and dosed with enzyme-treated gliadin, NOD/DQ8 mice did not show intestinal inflammation, when compared to mice challenged with only pepsin-treated gliadin. The low enzyme load needed for effective digestion suggests that gluten detoxification can be achieved in a meal setting, using metered dosing based on meal size. We demonstrate this by showing efficient antigen processing at total substrate-to-enzyme ratios exceeding 12,000:1.

LanguageEnglish
Pages30980
JournalScientific reports
Volume6
DOIs
StatusPublished - 2 Aug 2016

Fingerprint

Gliadin
Celiac Disease
Enzymes
Meals
Digestion
Glutens
Therapeutics
Enzyme Therapy
Gluten-Free Diet
Inbred NOD Mouse
Pepsin A
Antigen Presentation
Proteolysis
Stomach
Inflammation
T-Lymphocytes
Peptides
Proteins

Cite this

Rey, M., Yang, M., Lee, L., Zhang, Y., Sheff, J. G., Sensen, C. W., ... Schriemer, D. C. (2016). Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Scientific reports, 6, 30980. DOI: 10.1038/srep30980

Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. / Rey, Martial; Yang, Menglin; Lee, Linda; Zhang, Ye; Sheff, Joey G; Sensen, Christoph W; Mrazek, Hynek; Halada, Petr; Man, Petr; McCarville, Justin L; Verdu, Elena F; Schriemer, David C.

In: Scientific reports, Vol. 6, 02.08.2016, p. 30980.

Research output: Contribution to journalArticle

Rey, M, Yang, M, Lee, L, Zhang, Y, Sheff, JG, Sensen, CW, Mrazek, H, Halada, P, Man, P, McCarville, JL, Verdu, EF & Schriemer, DC 2016, 'Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease' Scientific reports, vol 6, pp. 30980. DOI: 10.1038/srep30980
Rey M, Yang M, Lee L, Zhang Y, Sheff JG, Sensen CW et al. Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Scientific reports. 2016 Aug 2;6:30980. Available from, DOI: 10.1038/srep30980
Rey, Martial ; Yang, Menglin ; Lee, Linda ; Zhang, Ye ; Sheff, Joey G ; Sensen, Christoph W ; Mrazek, Hynek ; Halada, Petr ; Man, Petr ; McCarville, Justin L ; Verdu, Elena F ; Schriemer, David C. / Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. In: Scientific reports. 2016 ; Vol. 6. pp. 30980
@article{78df432db527466c9473d8db5e8369fd,
title = "Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease",
abstract = "Celiac disease is triggered by partially digested gluten proteins. Enzyme therapies that complete protein digestion in vivo could support a gluten-free diet, but the barrier to completeness is high. Current options require enzyme amounts on the same order as the protein meal itself. In this study, we evaluated proteolytic components of the carnivorous pitcher plant (Nepenthes spp.) for use in this context. Remarkably low doses enhance gliadin solubilization rates, and degrade gliadin slurries within the pH and temporal constraints of human gastric digestion. Potencies in excess of 1200:1 (substrate-to-enzyme) are achieved. Digestion generates small peptides through nepenthesin and neprosin, the latter a novel enzyme defining a previously-unknown class of prolyl endoprotease. The digests also exhibit reduced TG2 conversion rates in the immunogenic regions of gliadin, providing a twin mechanism for evading T-cell recognition. When sensitized and dosed with enzyme-treated gliadin, NOD/DQ8 mice did not show intestinal inflammation, when compared to mice challenged with only pepsin-treated gliadin. The low enzyme load needed for effective digestion suggests that gluten detoxification can be achieved in a meal setting, using metered dosing based on meal size. We demonstrate this by showing efficient antigen processing at total substrate-to-enzyme ratios exceeding 12,000:1.",
author = "Martial Rey and Menglin Yang and Linda Lee and Ye Zhang and Sheff, {Joey G} and Sensen, {Christoph W} and Hynek Mrazek and Petr Halada and Petr Man and McCarville, {Justin L} and Verdu, {Elena F} and Schriemer, {David C}",
year = "2016",
month = "8",
day = "2",
doi = "10.1038/srep30980",
language = "English",
volume = "6",
pages = "30980",
journal = "Scientific reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease

AU - Rey,Martial

AU - Yang,Menglin

AU - Lee,Linda

AU - Zhang,Ye

AU - Sheff,Joey G

AU - Sensen,Christoph W

AU - Mrazek,Hynek

AU - Halada,Petr

AU - Man,Petr

AU - McCarville,Justin L

AU - Verdu,Elena F

AU - Schriemer,David C

PY - 2016/8/2

Y1 - 2016/8/2

N2 - Celiac disease is triggered by partially digested gluten proteins. Enzyme therapies that complete protein digestion in vivo could support a gluten-free diet, but the barrier to completeness is high. Current options require enzyme amounts on the same order as the protein meal itself. In this study, we evaluated proteolytic components of the carnivorous pitcher plant (Nepenthes spp.) for use in this context. Remarkably low doses enhance gliadin solubilization rates, and degrade gliadin slurries within the pH and temporal constraints of human gastric digestion. Potencies in excess of 1200:1 (substrate-to-enzyme) are achieved. Digestion generates small peptides through nepenthesin and neprosin, the latter a novel enzyme defining a previously-unknown class of prolyl endoprotease. The digests also exhibit reduced TG2 conversion rates in the immunogenic regions of gliadin, providing a twin mechanism for evading T-cell recognition. When sensitized and dosed with enzyme-treated gliadin, NOD/DQ8 mice did not show intestinal inflammation, when compared to mice challenged with only pepsin-treated gliadin. The low enzyme load needed for effective digestion suggests that gluten detoxification can be achieved in a meal setting, using metered dosing based on meal size. We demonstrate this by showing efficient antigen processing at total substrate-to-enzyme ratios exceeding 12,000:1.

AB - Celiac disease is triggered by partially digested gluten proteins. Enzyme therapies that complete protein digestion in vivo could support a gluten-free diet, but the barrier to completeness is high. Current options require enzyme amounts on the same order as the protein meal itself. In this study, we evaluated proteolytic components of the carnivorous pitcher plant (Nepenthes spp.) for use in this context. Remarkably low doses enhance gliadin solubilization rates, and degrade gliadin slurries within the pH and temporal constraints of human gastric digestion. Potencies in excess of 1200:1 (substrate-to-enzyme) are achieved. Digestion generates small peptides through nepenthesin and neprosin, the latter a novel enzyme defining a previously-unknown class of prolyl endoprotease. The digests also exhibit reduced TG2 conversion rates in the immunogenic regions of gliadin, providing a twin mechanism for evading T-cell recognition. When sensitized and dosed with enzyme-treated gliadin, NOD/DQ8 mice did not show intestinal inflammation, when compared to mice challenged with only pepsin-treated gliadin. The low enzyme load needed for effective digestion suggests that gluten detoxification can be achieved in a meal setting, using metered dosing based on meal size. We demonstrate this by showing efficient antigen processing at total substrate-to-enzyme ratios exceeding 12,000:1.

U2 - 10.1038/srep30980

DO - 10.1038/srep30980

M3 - Article

VL - 6

SP - 30980

JO - Scientific reports

T2 - Scientific reports

JF - Scientific reports

SN - 2045-2322

ER -